The emergence and re-emergence of infectious diseases continue to pose significant challenges to global public health. Advances in genomic technologies have revolutionized infectious disease surveillance by enabling rapid sequencing and analysis of pathogen genomes. Genomic surveillance provides critical insights into pathogen evolution, transmission dynamics, antimicrobial resistance, and outbreak detection. The COVID-19 pandemic highlighted the importance of genomic surveillance in guiding public health interventions and informing global response strategies.

Objective

This study evaluates the role of genomic surveillance in infectious disease management, focusing on outbreak detection, pathogen monitoring, antimicrobial resistance surveillance, and public health decision-making.

Methods

A retrospective multicenter analysis was conducted using genomic surveillance data from 45,000 pathogen samples collected between 2018 and 2024. Whole-genome sequencing data from viral, bacterial, and parasitic pathogens were analyzed to assess outbreak detection capabilities, variant tracking, antimicrobial resistance identification, and public health outcomes.

Results

Genomic surveillance enabled earlier outbreak detection in 82% of investigated events and improved pathogen lineage identification accuracy to 97%. Antimicrobial resistance markers were identified in 31% of bacterial isolates. Public health interventions informed by genomic surveillance reduced outbreak duration by 28% and improved containment efficiency by 35%.

Conclusion

Genomic surveillance plays a critical role in modern infectious disease management by enabling rapid pathogen characterization, outbreak tracking, and evidence-based public health interventions. Expanding genomic surveillance infrastructure and integrating genomic data into healthcare systems are essential for strengthening global health security.